Current issue

№2/2019

Volume 12 Issue 2

 

 

 

 

 

 

 

 

 

REVIEWS

Achievements and Challenges in Allogeneic Hematopoietic Stem Cell Transplantation in Cytogenetically Unfavorable Acute Leukemias (Literature Review)

Mamaev NN, Gindina TL, Afanas’ev BV

PDF

pdficon

Clinical Efficacy of Chelation Therapy in Patients with Low-Risk Myelodysplastic Syndrome

Gritsaev SV, Kostroma II, Zhernyakova AA

PDF

pdficon

Bispecific Antibodies in Clinical Practice and Clinical Trials (Literature Review)

Solopova ON, Misyurin VA

PDF

pdficon

LYMPHOID TUMORS

Blinatumomab in the Treatment of Acute Lymphoblastic Leukemia: Russian Multicenter Clinical Trial

Bondarenko SN, Parovichnikova EN, Maschan AA, Baranova OYu, Shelekhova TV, Doronin VA, Mel’nichenko VYa, Kaplanov KD, Uspenskaya OS, Sokolov AN, Myakova NV, Moiseev IS, Markova IV, Darskaya EI, Smirnova AG, Bykova TA, Ayubova BI, Samorodova IA, Babenko EV, Barkhatov IM, Gindina TL, Kulagin AD, Afanas’ev BV

PDF

pdficon

Analysis Results of the Regional Registry of Patients with Diffuse Large B-cell Lymphoma: Risk Factors and Chemo-Immunotherapy Issues

Kaplanov KD, Volkov NP, Klitochenko TYu, Matveeva IV, Shipaeva AL, Shirokova MN, Davydova NV, Gemdzhian EG, Abramov DS, Konovalov DM, Snigur GL, Red’kina NA

PDF

pdficon

Intermediate Results of Prospective Observational Study: The 2-year Experience of Ibrutinib Therapy in Relapsed/Refractory Mantle Cell Lymphoma in Clinical Practice

Vorob’ev VI, Zherebtsova VA, Dubrovin EI, Bychenkova LA, Kochkareva YuB, Mukha LA, Ivanova VL, Khuazheva NK, Ptushkin VV

PDF

pdficon

Prognostic Value of PRAME Activity in Tumor Cells of Follicular Lymphoma

Misyurin VA, Misyurina AE, Kravchenko SK, Lyzhko NA, Finashutina YuP, Kasatkina NN, Mar’in DS, Nesterova ES, Sharkunov NN, Baryshnikova MA, Misyurin AV

PDF

pdficon

Overcoming Resistance in Relapsed Anaplastic Large-Cell Lymphoma, ALK-Positive (Literature Review and Clinical Experience)

Vinogradova YuE, Chernova NG

PDF

pdficon

A Clinical and Pathological Comparison of Different Immunomorphological Subvariants of Nodular Lymphocyte-Predominant Hodgkin’s Lymphoma at Initial Diagnosis

Shupletsova IA, Kovrigina AM, Moiseeva TN, Dorokhina EI, Kulikov SM

PDF

pdficon

MYELOID TUMORS

Treatment of Chronic Myeloid Leukemia According to Current Guidelines: The Results of the Pilot Prospective Study “Early Induction Therapy and Monitoring” (РИТМ)

Shukhov OA, Turkina AG, Chelysheva EYu, Bykova AV, Petrova AN, Gusarova GA, Nemchenko IS, Abdullaev AO, Obukhova TN, Sudarikov AB

PDF

pdficon

Management of Chronic Myeloid Leukemia Patients During Pregnancy (Analysis of Literature and Practical Recommendations)

Chelysheva EYu, Turkina AG, Polushkina ES, Vinogradova MA, Shmakov RG

PDF

pdficon

Prognostic Value of Genetic Mutations in Patients with Acute Myeloid Leukemias: Results of a Cooperative Study of Hematology Clinics of Saint Petersburg (Russia) and Charite Clinic (Germany)

Motyko EV, Blau OV, Polushkina LB, Martynenko LS, Bakai MP, Tsybakova NYu, Ruzhenkova YuS, Kleina EV, Pavlenko NB, Radzhabova AM, Karyagina EV, Uspenskaya OS, Voloshin SV, Chechetkin AV, Martynkevich IS

PDF

pdficon

ANTINEOPLASTIC THERAPY COMPLICATIONS

Rhythm and Conduction Disorders in Patients Receiving Ibrutinib

Emelina EI, Gendlin GE, Nikitin IG, Dmitrieva EA, Nikitin EA, Ptushkin VV

PDF

pdficon

Infectious Complications in Multiple Myeloma Patients Receiving Various Antitumor Regimens

Novikova AA, Klyasova GA, Gribanova EO, Ryzhko VV, Tupoleva TA, Mendeleeva LP, Savchenko VG

PDF

pdficon

NEWS

Resolution of Expert Panel for the Targeted Therapy of Paroxysmal Nocturnal Hemoglobinuria

PDF

pdficon